Cargando…
Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
International and national guidelines on chronic obstructive pulmonary disease (COPD) emphasise bronchodilators as first-line therapy. However, in considering them the ‘foundation’ of treatment, attention has shifted from the fact that COPD is fundamentally an inflammatory disease. The mainstay ough...
Autores principales: | Irusen, Elvis M., Malange, Thandeka D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378153/ https://www.ncbi.nlm.nih.gov/pubmed/33314947 http://dx.doi.org/10.4102/safp.v62i1.5198 |
Ejemplares similares
-
The Global Initiative for Asthma 2019 recommendation for mild asthma – A critique
por: Irusen, Elvis M.
Publicado: (2020) -
Access considerations for a COVID-19 vaccine for South Africa
por: Bangalee, Varsha, et al.
Publicado: (2020) -
Social implications of autonomous vehicles: a focus on time
por: McCarroll, Cian, et al.
Publicado: (2022) -
Topical cannabidiol (CBD) in skin pathology – A comprehensive review and prospects for new therapeutic opportunities
por: Makhakhe, Lehlohonolo
Publicado: (2022) -
Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)